213 related articles for article (PubMed ID: 9847435)
1. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma.
Nelson HS; Bensch G; Pleskow WW; DiSantostefano R; DeGraw S; Reasner DS; Rollins TE; Rubin PD
J Allergy Clin Immunol; 1998 Dec; 102(6 Pt 1):943-52. PubMed ID: 9847435
[TBL] [Abstract][Full Text] [Related]
2. The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients.
Gawchik SM; Saccar CL; Noonan M; Reasner DS; DeGraw SS
J Allergy Clin Immunol; 1999 Apr; 103(4):615-21. PubMed ID: 10200010
[TBL] [Abstract][Full Text] [Related]
3. Dose-response evaluation of levalbuterol versus racemic albuterol in patients with asthma.
Handley DA; Tinkelman D; Noonan M; Rollins TE; Snider ME; Caron J
J Asthma; 2000 Jun; 37(4):319-27. PubMed ID: 10883742
[TBL] [Abstract][Full Text] [Related]
4. Pairwise comparison of levalbuterol versus racemic albuterol in the treatment of moderate-to-severe asthma.
Pleskow WW; Nelson HS; Schaefer K; Claus R; Roach JM
Allergy Asthma Proc; 2004; 25(6):429-36. PubMed ID: 15709454
[TBL] [Abstract][Full Text] [Related]
5. Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol.
Milgrom H; Skoner DP; Bensch G; Kim KT; Claus R; Baumgartner RA;
J Allergy Clin Immunol; 2001 Dec; 108(6):938-45. PubMed ID: 11742271
[TBL] [Abstract][Full Text] [Related]
6. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with levalbuterol.
Nelson HS
J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S77-84. PubMed ID: 10452792
[TBL] [Abstract][Full Text] [Related]
8. A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects.
Tripp K; McVicar WK; Nair P; Corren J; Pleskow WW; Goodwin E; Baumgartner RA; Hanrahan JP
J Allergy Clin Immunol; 2008 Sep; 122(3):544-9. PubMed ID: 18692886
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial.
Berger WE; Milgrom H; Skoner DP; Tripp K; Parsey MV; Baumgartner RA;
Curr Med Res Opin; 2006 Jun; 22(6):1217-26. PubMed ID: 16846555
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma.
Hamilos DL; D'Urzo A; Levy RJ; Marcus M; Tripp K; Parsey M; Baumgartner RA; McVicar WK
Ann Allergy Asthma Immunol; 2007 Dec; 99(6):540-8. PubMed ID: 18219836
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of nebulized levalbuterol in stable COPD.
Datta D; Vitale A; Lahiri B; ZuWallack R
Chest; 2003 Sep; 124(3):844-9. PubMed ID: 12970007
[TBL] [Abstract][Full Text] [Related]
12. Levalbuterol compared with racemic albuterol in the treatment of acute asthma: results of a pilot study.
Nowak RM; Emerman CL; Schaefer K; Disantostefano RL; Vaickus L; Roach JM
Am J Emerg Med; 2004 Jan; 22(1):29-36. PubMed ID: 14724875
[TBL] [Abstract][Full Text] [Related]
13. Levalbuterol versus albuterol for acute asthma: a systematic review and meta-analysis.
Jat KR; Khairwa A
Pulm Pharmacol Ther; 2013 Apr; 26(2):239-48. PubMed ID: 23207739
[TBL] [Abstract][Full Text] [Related]
14. Comparison of racemic albuterol and levalbuterol in the treatment of acute asthma in the ED.
Schreck DM; Babin S
Am J Emerg Med; 2005 Nov; 23(7):842-7. PubMed ID: 16291438
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
16. Comparison of racemic albuterol and levalbuterol for treatment of acute asthma.
Carl JC; Myers TR; Kirchner HL; Kercsmar CM
J Pediatr; 2003 Dec; 143(6):731-6. PubMed ID: 14657817
[TBL] [Abstract][Full Text] [Related]
17. A comparison of heart rate changes associated with levalbuterol and racemic albuterol in pediatric cardiology patients.
Kelly A; Kennedy A; John BM; Duane B; Lemanowicz J; Little J
Ann Pharmacother; 2013 May; 47(5):644-50. PubMed ID: 23613097
[TBL] [Abstract][Full Text] [Related]
18. A patient satisfaction survey comparing levalbuterol with racemic albuterol in children.
Berger WE; Ames DE; Harrison D
Allergy Asthma Proc; 2004; 25(6):437-44. PubMed ID: 15709455
[TBL] [Abstract][Full Text] [Related]
19. The asthma-like pharmacology and toxicology of (S)-isomers of beta agonists.
Handley D
J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S69-76. PubMed ID: 10452791
[TBL] [Abstract][Full Text] [Related]
20. Levalbuterol in the treatment of patients with asthma and chronic obstructive lung disease.
Dalonzo GE
J Am Osteopath Assoc; 2004 Jul; 104(7):288-93. PubMed ID: 15293593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
